WEC
CELG

Winslow Evans & Crocker’s Celgene Corp CELG Stock Holding History

Winslow Evans & Crocker’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,072
Closed -$704K – 1178
2019
Q3 		$704K Sell
7,072
-310
-4% -$29.5K 0.2% 111
2019
Q2 		$686K Sell
7,382
-466
-6% -$44.3K 0.19% 119
2019
Q1 		$744K Sell
7,848
-1,450
-16% -$127K 0.21% 107
2018
Q4 		$598K Sell
9,298
-1,130
-11% -$83.4K 0.2% 110
2018
Q3 		$936K Buy
10,428
+680
+7% +$60.1K 0.28% 86
2018
Q2 		$778K Sell
9,748
-2,772
-22% -$230K 0.24% 101
2018
Q1 		$1.12M Buy
12,520
+740
+6% +$71K 0.36% 65
2017
Q4 		$1.23M Buy
11,780
+2,404
+26% +$271K 0.4% 57
2017
Q3 		$1.37M Sell
9,376
-221
-2% -$30.1K 0.45% 53
2017
Q2 		$1.25M Buy
9,597
+1,117
+13% +$137K 0.34% 70
2017
Q1 		$1.05M Sell
8,480
-342
-4% -$40.9K 0.33% 64
2016
Q4 		$1.02M Sell
8,822
-1,680
-16% -$187K 0.31% 72
2016
Q3 		$1.1M Buy
10,502
+1,672
+19% +$181K 0.31% 72
2016
Q2 		$871K Sell
8,830
-153
-2% -$15.8K 0.26% 91
2016
Q1 		$899K Buy
8,983
+9
+0.1% +$927 0.27% 89
2015
Q4 		$1.07M Sell
8,974
-190
-2% -$22K 0.31% 78
2015
Q3 		$991K Buy
9,164
+1,344
+17% +$167K 0.31% 73
2015
Q2 		$905K Buy
7,820
+48
+0.6% +$5.49K 0.26% 90
2015
Q1 		$896K Buy
7,772
+174
+2% +$20.8K 0.25% 89
2014
Q4 		$850K Sell
7,598
-1,668
-18% -$176K 0.24% 91
2014
Q3 		$878K Buy
9,266
+7,239
+357% +$653K 0.25% 102
2014
Q2 		$174K Sell
2,027
-1,891
-48% -$144K 0.06% 279
2014
Q1 		$273K Buy
3,918
+400
+11% +$31.7K 0.09% 226
2013
Q4 		$297K Buy
+3,518
New +$278K 0.1% 222

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Winslow Evans & Crocker's CELG Position: Q4 2019 in Review

Winslow Evans & Crocker sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,072 shares — an estimated $704K sold.

Winslow Evans & Crocker first reported a position in CELG in Q4 2013 and held it in 24 quarters. The position peaked at $1.37M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Winslow Evans & Crocker reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Winslow Evans & Crocker sold 7,072 Celgene Corp shares in Q4 2019, an estimated $704K.
  • Winslow Evans & Crocker first reported a position in Celgene Corp in Q4 2013 and held it in 24 quarters.
  • Winslow Evans & Crocker's Celgene Corp position peaked at $1.37M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Winslow Evans & Crocker's 13F filing for Q4 2019, filed 14 Jan 2020.